Status:
RECRUITING
Coronary Microvascular Dysfunction in Angina Patients With Non-obstructive Coronary Artery Disease (ANOCA-CMD)
Lead Sponsor:
China-Japan Friendship Hospital
Conditions:
Angina Patients With Non-obstructive Coronary Artery Disease
Coronary Microvascular Dysfunction
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to explore the incidence and effect on prognosis of coronary microvascular dysfunction in patients present of stable anginal symptoms, a clinical indication for...
Eligibility Criteria
Inclusion
- presence of stable anginal symptoms, a clinical indication for invasive coronary angiography, and no hemodynamically significant epicardial coronary artery disease, defined as fractional flow reserve (FFR) \>0.80
Exclusion
- acute myocardial infarction
- significant valvular heart disease
- advanced chronic kidney disease
- patients with significant epicardial coronary artery stenosis (\>70% in major vessels by diagnostic coronary angiography) needing percutaneous coronary intervention
- patients unable to provide written informed consent
Key Trial Info
Start Date :
July 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06503640
Start Date
July 1 2023
End Date
December 31 2025
Last Update
July 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China, 100029